Perpetual LTD Abb Vie Inc. Transaction History

Perpetual LTD

$10.2 Trillion
Q1 2024

A detailed history of Perpetual LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Perpetual LTD holds 18,973 shares of ABBV stock, worth $3.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,973

Previous 18,973 -0.0%

Holding current value

$3.06 Million

Previous $3.45 Billion -0.0%

% of portfolio

0.03%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $497,359 - $566,695	-3,112 Reduced 14.09%	18,973 $3.45 Billion
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $219,196 - $246,867	1,593 Added 7.77%	22,085 $3.42 Billion
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $479,855 - $555,502	3,592 Added 21.25%	20,492 $3.05 Billion
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $1.55 Million - $1.78 Million	-10,700 Reduced 38.77%	16,900 $2.69 Billion
Q2 2020 Nov 18, 2020	BUY	$73.37 - $98.18 $2.03 Million - $2.71 Million	27,600 New	27,600 $5.72 Million

Q1 2020 Nov 18, 2020	SELL	$64.5 - $97.79 $1.78 Million - $2.7 Million	-27,600 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $233,026 - $280,164	3,700 Added 15.48%	27,600 $2.09 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $1.57 Million - $2.01 Million	23,900 New	23,900 $1.74 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $1.08 Million - $1.2 Million	-12,155 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$89.78 - $106.23 $1.09 Million - $1.29 Million	12,155 New	12,155 $1.13 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.

Account